CatalYm announced the appointment of Scott Clarke as Chief Executive Officer. Mr. Clarke brings over two decades of executive leadership experience in driving company...
Geron Corporation, a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, announced the appointment of Joseph Eid, M.D....
Nocion Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions”, that selectively silence actively firing nociceptors...
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and...
Abzena, the leading end-to-end integrated contract and development manufacturing organization for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving...
